Search
for
Sort by
Research 571–600 of 1000+
- Localized corticosteroid delivery in alopecia areata using microneedle patch technology
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- LB1012 The development of a pediatric alopecia areata treatment classification system based on results from a systematic review
- Quality-of-Life Assessment in Singaporean Children with Alopecia Areata
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- 229 Single cell transcriptomics identifies a potential role for Arg1+ macrophages in alopecia areata pathogenesis
- 526 Gut dysbiosis in alopecia areata patients reveals overabundance of firmicutes and under representation of bacteroides
- Recent Advances in the Pathogenesis of Autoimmune Hair Loss Disease Alopecia Areata
- A systematic review of pulse steroid therapy for alopecia areata
- New aspects of the treatment of alopecia areata
- Current Protocols: Alopecia Areata Mouse Models for Drug Efficacy and Mechanism Studies
- No todo es efluvio telógeno. Alopecia areata difusa una entidad infradiagnosticada
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Human Leukocyte Antigen Class II Alleles Are Associated with Risk of Alopecia Areata
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Assessment of vitamin D levels in patients with alopecia areata: a case-control study in a Tertiary Care Hospital in North India
- Recurrence of Alopecia Areata in a Patient Receiving Etanercept Injections
- Functional Interpretation of Genome-Wide Association Study Evidence in Alopecia Areata
- Alopecia areata-successful outcome with microneedling and triamcinolone acetonide
- Clobetasol Propionate, 0.05%, vs Hydrocortisone, 1%, for Alopecia Areata in Children
- Prevalence of pediatric alopecia areata among 572,617 dermatology patients
- A transcriptomic map of murine and human alopecia areata
- SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- Response of alopecia areata of the beard to oral tofacitinib
- Annular alopecia areata: Report of two cases
- Evaluation of quality of life scores and family impact scales in pediatric patients with alopecia areata: a cross‐sectional cohort study
- Intralesional vitamin D3 in treatment of alopecia areata: A randomized controlled clinical trial